Patents by Inventor Douglas Webster
Douglas Webster has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11998974Abstract: A casting core used in the manufacture of a cast engine component for a turbine engine, the cast engine component having a first area, a second area, a fluid passage wall separating the first area and the second area, and a connecting fluid passage extending through the fluid passage wall and interconnecting the first area and the second area. The connecting fluid passage having a turn with a radius (R). The casting core having a first core and a second core. The first core and the second core being defined by a set of geometric characteristics having a first minimum equivalent diameter (D1eqmin) of the first core and a second minimum equivalent diameter (D2eqmin) of the second core. A first flexible geometry factor (FGF1) being equal to: ( D ? 1 eq ? min D ? 2 eq ? min ) ? ( R D ? 2 eq ? min ) .Type: GrantFiled: August 30, 2022Date of Patent: June 4, 2024Assignee: General Electric CompanyInventors: Daniel Endecott Osgood, Zachary Daniel Webster, Craig Alan Gonyou, Daniel Lee Durstock, Kevin R. Feldmann, Kirk Douglas Gallier, William C. Herman, Nicholas Charles Gentilli
-
Patent number: 11988109Abstract: An apparatus and method for an engine component for a turbine engine. The engine component having an outer wall defining an interior and extending between a root and a tip to define a radial direction, a tip wall spanning the first side and second sides to close the interior at the tip. A tip rail extending from the tip wall and having an inner tip rail surface, an outer tip rail surface extending from at least one of the first or the second side, and radially terminating in an upper tip rail surface connecting the inner tip rail surface and the outer tip rail surface. A tip rim formed in at least one of the outer surface or the inner tip rail surface and spaced from the upper tip rail surface in the radial direction, and multiple cooling passages formed in the outer wall and fluidly coupling the at least one cooling conduit to the tip rim at corresponding passage outlets.Type: GrantFiled: October 26, 2022Date of Patent: May 21, 2024Assignee: General Electric CompanyInventors: Zachary Daniel Webster, Daniel Endecott Osgood, Kirk Douglas Gallier
-
Publication number: 20240114027Abstract: A system for authenticating a medical device is described. The system receives a request from a medical device to access operations or data of an external service provider. The system determines whether the request received from the medical device is valid. When the request is valid, the system generates a token that is customized based on the external service provider identified in the request, and the system transfers the token to medical device, the token enabling the medical device to access the operations or data of the external service provider.Type: ApplicationFiled: September 18, 2023Publication date: April 4, 2024Inventors: David D. Gamble, Douglas Fenster, Adam Webster
-
Patent number: 11927111Abstract: A blade for a turbine engine with a wall separating a cooling fluid flow and a hot gas fluid flow and having a heated surface along which the hot gas fluid flow flows and a cooled surface facing the cooling fluid flow. A plurality of cooling holes each having a passage extending between an inlet at the cooled surface and an outlet at the heated surface. The outlet extending between an upstream end and a downstream end with respect to the hot gas fluid flow to define a distance, the passage defining a centerline forming a first angle (?) with the heated surface.Type: GrantFiled: June 9, 2022Date of Patent: March 12, 2024Assignee: General Electric CompanyInventors: Jonathan Michael Rausch, Zachary Daniel Webster, Kevin Robert Feldmann, Andrew David Perry, Kirk Douglas Gallier, Daniel Endecott Osgood
-
Publication number: 20240066588Abstract: A casting core used in the manufacture of a cast engine component for a turbine engine, the cast engine component having a first area, a second area, a fluid passage wall separating the first area and the second area, and a connecting fluid passage extending through the fluid passage wall and interconnecting the first area and the second area. The connecting fluid passage having a turn with a radius (R). The casting core having a first core and a second core. The first core and the second core being defined by a set of geometric characteristics having a first minimum equivalent diameter (D1eqmin) of the first core and a second minimum equivalent diameter (D2eqmin) of the second core. A first flexible geometry factor (FGF1) being equal to: ( D ? 1 eq ? min D ? 2 eq ? min ) ? ( R D ? 2 eq ? min ) .Type: ApplicationFiled: August 30, 2022Publication date: February 29, 2024Inventors: Daniel Endecott Osgood, Zachary Daniel Webster, Craig Alan Gonyou, Daniel Lee Durstock, Kevin R. Feldmann, Kirk Douglas Gallier, William C. Herman, Nicholas Charles Gentilli
-
Publication number: 20230185279Abstract: A computer numerically controlled machine may include a source configured to deliver an electromagnetic energy to at least one location within an interior space of the computer-numerically-controlled machine. The electromagnetic energy may have a first range of wavelengths from a visible spectrum. An enclosure defining at least a portion of the interior space of the computer numerically controlled machine may include a transparent portion configured to filter the first range of wavelengths associated with the electromagnetic energy. Moreover, the transparent portion may reflect and/or transmit at least a second range of wavelengths from the visible spectrum not associated with the electromagnetic energy such that the transparent portion of the enclosure exhibits a first color corresponding to the second range of wavelengths.Type: ApplicationFiled: October 17, 2022Publication date: June 15, 2023Inventors: Daniel Shapiro, Mark Gosselin, Douglas Webster
-
Patent number: 11179404Abstract: The present application is directed to an aqueous pharmaceutical formulation comprising less than about 5% w/v sodium deoxycholate maintained at a pH sufficient to substantially inhibit precipitation of the sodium deoxycholate. Also disclosed herein, are methods for inhibiting precipitation of sodium deoxycholate in an aqueous solution comprising less than about 5% w/v of sodium deoxycholate, said method comprising maintaining pH of the solution of from at least about 8.0 to about 8.5.Type: GrantFiled: November 7, 2019Date of Patent: November 23, 2021Assignee: Allergan Sales, LLCInventors: Robert Emil Hodge, Jeffrey Douglas Webster
-
Publication number: 20210252021Abstract: The present application is directed to an aqueous pharmaceutical composition comprising from about 0.4% w/v to less than about 2% w/v of a salt of deoxycholic acid, wherein the composition is maintained at a pH from about 8.1 to about 8.5 such that the composition is stabilized against precipitation. Also disclosed herein, are methods for stabilizing an aqueous pharmaceutical composition comprising from about 0.4% w/v to less than about 2% w/v of a salt of deoxycholic acid against precipitation, said method comprising maintaining pH of the solution from about 8.1 to about 8.5.Type: ApplicationFiled: February 17, 2021Publication date: August 19, 2021Applicant: ALLERGAN SALES, LLCInventors: Robert Emil Hodge, Jeffrey Douglas Webster, Robert M. Moriarty
-
Patent number: 10946030Abstract: The present application is directed to an aqueous pharmaceutical composition comprising from about 0.4% w/v to less than about 2% w/v of a salt of deoxycholic acid, wherein the composition is maintained at a pH from about 8.1 to about 8.5 such that the composition is stabilized against precipitation. Also disclosed herein, are methods for stabilizing an aqueous pharmaceutical composition comprising from about 0.4% w/v to less than about 2% w/v of a salt of deoxycholic acid against precipitation, said method comprising maintaining pH of the solution from about 8.1 to about 8.5.Type: GrantFiled: July 28, 2017Date of Patent: March 16, 2021Assignee: Allergan Sales, LLCInventors: Robert Emil Hodge, Jeffrey Douglas Webster, Robert M. Moriarty
-
Publication number: 20200188414Abstract: The present application is directed to an aqueous pharmaceutical formulation comprising less than about 5% w/v sodium deoxycholate maintained at a pH sufficient to substantially inhibit precipitation of the sodium deoxycholate. Also disclosed herein, are methods for inhibiting precipitation of sodium deoxycholate in an aqueous solution comprising less than about 5% w/v of sodium deoxycholate, said method comprising maintaining pH of the solution of from at least about 8.0 to about 8.Type: ApplicationFiled: November 7, 2019Publication date: June 18, 2020Inventors: Robert Emil Hodge, Jeffrey Douglas Webster
-
Patent number: 10500214Abstract: The present application is directed to an aqueous pharmaceutical formulation comprising less than about 5% w/v sodium deoxycholate maintained at a pH sufficient to substantially inhibit precipitation of the sodium deoxycholate. Also disclosed herein, are methods for inhibiting precipitation of sodium deoxycholate in an aqueous solution comprising less than about 5% w/v of sodium deoxycholate, said method comprising maintaining pH of the solution of from at least about 8.0 to about 8.5.Type: GrantFiled: August 14, 2018Date of Patent: December 10, 2019Assignee: ALLERGAN SALES, LLCInventors: Robert Emil Hodge, Jeffrey Douglas Webster
-
Publication number: 20190038638Abstract: The present application is directed to an aqueous pharmaceutical formulation comprising less than about 5% w/v sodium deoxycholate maintained at a pH sufficient to substantially inhibit precipitation of the sodium deoxycholate. Also disclosed herein, are methods for inhibiting precipitation of sodium deoxycholate in an aqueous solution comprising less than about 5% w/v of sodium deoxycholate, said method comprising maintaining pH of the solution of from at least about 8.0 to about 8.5.Type: ApplicationFiled: August 14, 2018Publication date: February 7, 2019Applicant: Kythera Biopharmaceuticals, Inc.Inventors: Robert Emil HODGE, Jeffrey Douglas WEBSTER
-
Patent number: 10071105Abstract: The present application is directed to an aqueous pharmaceutical formulation comprising less than about 5% w/v sodium deoxycholate maintained at a pH sufficient to substantially inhibit precipitation of the sodium deoxycholate. Also disclosed herein, are methods for inhibiting precipitation of sodium deoxycholate in an aqueous solution comprising less than about 5% w/v of sodium deoxycholate, said method comprising maintaining pH of the solution of from at least about 8.0 to about 8.5.Type: GrantFiled: July 14, 2017Date of Patent: September 11, 2018Assignee: Kythera Biopharmaceuticals, Inc.Inventors: Robert Emil Hodge, Jeffrey Douglas Webster
-
Patent number: 9968864Abstract: A multi-body self-propelled device can include a drive body and a coupled head. The drive body can include a spherical housing and an internal drive system within the spherical housing to propel the multi-body self-propelled device. The drive body can further include a magnet support assembly comprising a rotating portion including a plurality of magnets and a stationary portion comprising one or more magnets. The drive body can further include a yaw motor to drive the rotating portion of the magnet support assembly. The coupled head can include (i) a corresponding rotating portion comprising a plurality of magnets in magnetic interaction, through the spherical housing, with the plurality of magnets of the magnet support assembly, and (ii) a corresponding stationary portion comprising one or more magnets in magnetic interaction with the one or more magnets of the magnet support assembly.Type: GrantFiled: May 17, 2016Date of Patent: May 15, 2018Assignee: SPHERO, INC.Inventors: David Clarke, Douglas Webster, Judd Nutting, Miles Keeney-Ritchie, Adam Short, Ross MacGregor
-
Publication number: 20180015105Abstract: The present application is directed to an aqueous pharmaceutical composition comprising from about 0.4% w/v to less than about 2% w/v of a salt of deoxycholic acid, wherein the composition is maintained at a pH from about 8.1 to about 8.5 such that the composition is stabilized against precipitation. Also disclosed herein, are methods for stabilizing an aqueous pharmaceutical composition comprising from about 0.4% w/v to less than about 2% w/v of a salt of deoxycholic acid against precipitation, said method comprising maintaining pH of the solution from about 8.1 to about 8.5.Type: ApplicationFiled: July 28, 2017Publication date: January 18, 2018Applicant: Kythera Biopharmaceuticals, Inc.Inventors: Robert Emil Hodge, Jeffrey Douglas Webster, Robert M. Moriarty
-
Publication number: 20180000835Abstract: The present application is directed to an aqueous pharmaceutical formulation comprising less than about 5% w/v sodium deoxycholate maintained at a pH sufficient to substantially inhibit precipitation of the sodium deoxycholate. Also disclosed herein, are methods for inhibiting precipitation of sodium deoxycholate in an aqueous solution comprising less than about 5% w/v of sodium deoxycholate, said method comprising maintaining pH of the solution of from at least about 8.0 to about 8.5.Type: ApplicationFiled: July 14, 2017Publication date: January 4, 2018Applicant: Kythera Biopharmaceuticals, Inc.Inventors: Robert Emil Hodge, Jeffrey Douglas Webster
-
Publication number: 20170266577Abstract: A multi-body self-propelled device can include a drive body and a coupled head. The drive body can include a spherical housing and an internal drive system within the spherical housing to propel the multi-body self-propelled device. The drive body can further include a magnet support assembly comprising a rotating portion including a plurality of magnets and a stationary portion comprising one or more magnets. The drive body can further include a yaw motor to drive the rotating portion of the magnet support assembly. The coupled head can include (i) a corresponding rotating portion comprising a plurality of magnets in magnetic interaction, through the spherical housing, with the plurality of magnets of the magnet support assembly, and (ii) a corresponding stationary portion comprising one or more magnets in magnetic interaction with the one or more magnets of the magnet support assembly.Type: ApplicationFiled: May 17, 2016Publication date: September 21, 2017Inventors: David Clarke, Douglas Webster, Judd Nutting, Miles Keeney-Ritchie, Adam Short, Ross MacGregor
-
Publication number: 20170266576Abstract: A multi-body self-propelled device can include a drive body and a coupled head. The drive body can include a spherical housing and an internal drive system within the spherical housing to propel the multi-body self-propelled device. The drive body can further include a magnet holder coupled to the internal drive system to hold a first set of magnetic elements. The coupled head can include a base plate to hold a second set of magnetic elements to create a magnetic interaction with the first set of magnetic elements through the spherical housing. The coupled head can further include a housing structure and a yaw motor that rotates the housing structure independently in relation to the base plate and the drive body.Type: ApplicationFiled: May 17, 2016Publication date: September 21, 2017Inventors: David Clarke, Douglas Webster, Ross MacGregor
-
Patent number: 9737549Abstract: The present application is directed to an aqueous pharmaceutical composition comprising from about 0.4% w/v to less than about 2% w/v of a salt of deoxycholic acid, wherein the composition is maintained at a pH from about 8.1 to about 8.5 such that the composition is stabilized against precipitation. Also disclosed herein, are methods for stabilizing an aqueous pharmaceutical composition comprising from about 0.4% w/v to less than about 2% w/v of a salt of deoxycholic acid against precipitation, said method comprising maintaining pH of the solution from about 8.1 to about 8.5.Type: GrantFiled: November 26, 2013Date of Patent: August 22, 2017Assignee: Kythera Biopharmaceuticals, Inc.Inventors: Robert Emil Hodge, Jeffrey Douglas Webster, Robert M. Moriarty
-
Patent number: 9724356Abstract: The present application is directed to an aqueous pharmaceutical formulation comprising less than about 5% w/v sodium deoxycholate maintained at a pH sufficient to substantially inhibit precipitation of the sodium deoxycholate. Also disclosed herein, are methods for inhibiting precipitation of sodium deoxycholate in an aqueous solution comprising less than about 5% w/v of sodium deoxycholate, said method comprising maintaining pH of the solution of from at least about 8.0 to about 8.5.Type: GrantFiled: February 7, 2014Date of Patent: August 8, 2017Assignee: Kythera Biopharmaceuticals, Inc.Inventors: Robert Emil Hodge, Jeffrey Douglas Webster